Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IMAX
IMAX logo

IMAX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Imax Corp (IMAX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
40.130
1 Day change
3.86%
52 Week Range
43.160
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

IMAX is not a strong buy at the moment for a beginner investor with a long-term focus. While the company shows positive growth trends in revenue and gross margin, the significant drop in net income and EPS, combined with insider selling and neutral hedge fund sentiment, suggests caution. Additionally, technical indicators do not signal a strong entry point, and no proprietary trading signals are present to support immediate action. The stock may be worth monitoring for future opportunities, but it does not currently align with the user's investment strategy.

Technical Analysis

The MACD is below 0 and negatively contracting, RSI is neutral at 42.985, and moving averages are converging. The stock is trading near its pivot point of 37.727, with resistance levels at 39.098 and 39.945, and support levels at 36.355 and 35.508. No strong trend or breakout signal is evident.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
9

Positive Catalysts

  • IMAX reported a 35.11% YoY increase in revenue for Q4 2025, driven by strong box office performance and system installs. The company is benefiting from a resurgence in theater audiences and has a pipeline of high-profile films like 'The Mandalorian and Grogu' and 'The Odyssey.' Project Hail Mary has demonstrated strong global appeal, particularly in China.

Neutral/Negative Catalysts

  • Insiders have significantly increased their selling activity by 486.11% over the last month. Hedge funds remain neutral, and technical indicators do not suggest a strong buying opportunity. Analyst ratings are mixed, with some maintaining neutral positions despite raising price targets.

Financial Performance

In Q4 2025, IMAX achieved a 35.11% YoY revenue increase to $125.2M and a gross margin improvement to 55.96%. However, net income dropped significantly by 87.99% YoY to $637K, and EPS fell by 90.00% YoY to $0.01, indicating profitability challenges.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have raised price targets, with the highest being $48, but opinions are mixed. Goldman Sachs maintains a Neutral rating, while Benchmark, B. Riley, and JPMorgan have Buy or Overweight ratings, citing strong revenue and margin performance.

Wall Street analysts forecast IMAX stock price to rise
12 Analyst Rating
Wall Street analysts forecast IMAX stock price to rise
11 Buy
1 Hold
0 Sell
Strong Buy
Current: 38.640
sliders
Low
34
Averages
44
High
47
Current: 38.640
sliders
Low
34
Averages
44
High
47
Goldman Sachs
Stephen Laszczyk
Neutral
downgrade
$720 -> $519
AI Analysis
2026-03-02
Reason
Goldman Sachs
Stephen Laszczyk
Price Target
$720 -> $519
AI Analysis
2026-03-02
downgrade
Neutral
Reason
Goldman Sachs analyst Stephen Laszczyk lowered the firm's price target on Imax to $519 from $720 and keeps a Neutral rating on the shares.
Goldman Sachs
Neutral
maintain
$37 -> $41
2026-03-02
Reason
Goldman Sachs
Price Target
$37 -> $41
2026-03-02
maintain
Neutral
Reason
Goldman Sachs raised the firm's price target on Imax to $41 from $37 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for IMAX
Unlock Now

People Also Watch